Article
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease.
Pharmacogenetics and genomics - 1 Jul 2026
Alkhalifa Mohammed, Dela Cruz Gio R, Ponich Terry, Gregor James C, Yan Brian, Khanna Reena, McIntosh Keith, Beaton Melanie D, Kim Richard B, Wilson Aze
Abstract excerpt
OBJECTIVES: A genome-wide association study identified that genetic variation in the twisted gastrulation protein homolog-1 gene ( TWSG1 rs7242593) was linked to early clinical remission in ustekinumab-exposed patients in the UNITI clinical trials. We aimed to confirm if a single nucleotide variation (SNV) in the TWSG1 gene is associated with clinical remission in inflammatory bowel disease (IBD) patients on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
